Samsara BioCapital’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Samsara BioCapital’s Portfolio DBTX Stock Details DBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-801,629	Closed	-$3.09M	–	47
2023 Q2	$3.09M	Hold	801,629	–	–	0.54%	25
2023 Q1	$2.42M	Hold	801,629	–	–	0.5%	30
2022 Q4	$1.64M	Hold	801,629	–	–	0.35%	34
2022 Q3	$2.77M	Hold	801,629	–	–	0.65%	31
2022 Q2	$3.38M	Sell	801,629 -24,793	-3%	-$58.6K	0.9%	26
2022 Q1	$2.51M	Hold	826,422	–	–	0.63%	34
2021 Q4	$3.84M	Hold	826,422	–	–	0.75%	27
2021 Q3	$6.37M	Hold	826,422	–	–	1%	23
2021 Q2	$7.11M	Hold	826,422	–	–	0.88%	22
2021 Q1	$9.39M	Buy	+826,422	New	+$13M	1.73%	16

Other funds holding DBTX

ACA

Atlas Capital Advisors Jackson, Wyoming $875M AUM

Samsara BioCapital's DBTX Position: Q3 2023 in Review

Samsara BioCapital sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 801,629 shares — an estimated $3.09M sold.

Samsara BioCapital first reported a position in DBTX in Q1 2021 and held it in 10 quarters. The position peaked at $9.39M in Q1 2021. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

Samsara BioCapital reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Samsara BioCapital sold 801,629 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $3.09M.
Samsara BioCapital first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
Samsara BioCapital's Decibel Therapeutics, Inc. Common Stock position peaked at $9.39M in Q1 2021.
1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Samsara BioCapital's 13F filing for Q3 2023, filed 14 Nov 2023.